pyrroles has been researched along with Spondylitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coates, LC; Deal, C; Deodhar, A; Dubreuil, M; Dunham, J; Gladman, DD; Gottlieb, A; Guyatt, G; Husni, ME; Jonsson, AH; Kenny, S; Kwan-Morley, J; Lin, J; Magrey, M; Marchetta, P; Mease, PJ; Merola, JF; Miner, J; Nowell, WB; Ogdie, A; Orbai, AM; Reddy, SM; Reston, J; Ritchlin, CT; Scher, JU; Shah, AA; Siaton, B; Siegel, E; Siegel, M; Singh, JA; Smith, BJ; Sullivan, N; Turgunbaev, M; Turner, AS; Van Voorhees, AS; Walsh, JA | 1 |
1 other study(ies) available for pyrroles and Spondylitis
Article | Year |
---|---|
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
Topics: Abatacept; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Comorbidity; Diabetes Mellitus; Enthesopathy; Etanercept; Evidence-Based Medicine; Exercise; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Interleukin-12; Interleukin-17; Interleukin-23; Occupational Therapy; Physical Therapy Modalities; Piperidines; Pyrimidines; Pyrroles; Rheumatology; Smoking Cessation; Societies, Medical; Spondylitis; Tumor Necrosis Factor-alpha; Ustekinumab; Weight Loss | 2019 |